Second Primary Malignancy after Radioiodine Treatment of Thyroid Disease: Current Status
نویسندگان
چکیده
Other SectionsAbstract서 론방사선과 발암분화갑상선암의 I-131 치료와 이차암 발생갑상선기능항진증의 발생결 론Conflicts of InterestReference
منابع مشابه
Second malignancy after treatment of pediatric Hodgkin disease.
Although treatment of pediatric Hodgkin disease has become highly effective over the past 40 years, a number of patients have developed concerning late effects, such as secondary malignancies. These cancers may occur years to decades after remission and arise in the breast, thyroid, gastrointestinal tract, lung, skin, urogenital tract, and brain. There is also an increased risk of leukemia and ...
متن کاملRadioiodine therapy of thyroid disease.
Ten "ideal" steps used at the University of Michigan to treat well-differentiated thyroid cancer are presented. Using this in 103 patients with well-differentiated thyroid carcinoma and metastases outside their neck, those that were freed of their disease after 131I therapy survived three times as long as those not cured of their disease. Patients successfully cured of their metastases showed b...
متن کاملPregnancy outcome after treatment with radioiodine for differentiated thyroid carcinoma.
The aim of the study was to investigate the influence of radioiodine (RAI) therapy on pregnancies and the health status of children born to mothers who had received therapeutic doses of I-131 for differentiated thyroid carcinoma (DTC). Gestational histories of 76 women treated for DTC from 1971-2005 were retrospectively analyzed. The outcome of 49 pregnancies after RAI was: 35 children (72%), 5...
متن کاملAcute leukemias after treatment with radioiodine for thyroid cancer.
Leukemia is an uncommon complication of exposure to radioiodine (131I), used in treatment of thyroid cancer, because low doses are now used. We report two cases of acute myelogenous leukemia developed after the treatment of a thyroid carcinoma with a small dose of 131I.
متن کاملRadioiodine and thyroid eye disease.
1 NHS Executive. The new NHS: a national framework for assessing performance. London: Department of Health, 1998. 2 Bindman A B, Grumbach K, Osmond D, Komarony M, Vranizan K, Lurie N, et al. Preventable hospitalisations and access to health care. JAMA 1995;274:305-11. 3 Reid FDA, Cook D, Majeed FA. Variation in hospital admission rates between general practices: cross sectional study. BMJ 1999;...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International journal of thyroidology
سال: 2023
ISSN: ['2384-3799', '2466-1899']
DOI: https://doi.org/10.11106/ijt.2023.16.1.101